These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6086703)

  • 1. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
    Sheridan JF; Aurelian L; Donnenberg AD; Quinn TC
    J Clin Immunol; 1984 Jul; 4(4):304-11. PubMed ID: 6086703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of virus-specific immunity in vitro by the addition of interleukin-1 and interleukin-2 in patients with the acquired immune deficiency syndrome.
    Sheridan JF; Aurelian L; Quinn TC
    Ann N Y Acad Sci; 1984; 437():530-4. PubMed ID: 6100007
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific stimulation of lymphocytes from patients with AIDS by herpes simplex virus antigens.
    Wainberg MA; Portnoy J; Tsoukas C; Gilmore N
    Immunology; 1987 Feb; 60(2):275-80. PubMed ID: 3028941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune response to human cytomegalovirus. I. Lymphocyte transformation studies in the rabbit.
    Lausch RN; Jones C; Christensen RC
    Intervirology; 1979; 11(2):74-81. PubMed ID: 85612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy.
    Pass RF; Dworsky ME; Whitley RJ; August AM; Stagno S; Alford CA
    Infect Immun; 1981 Oct; 34(1):166-70. PubMed ID: 6271679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome.
    Epstein JS; Frederick WR; Rook AH; Jackson L; Manischewitz JF; Mayner RE; Masur H; Enterline JC; Djeu JY; Quinnan GV
    J Infect Dis; 1985 Oct; 152(4):727-33. PubMed ID: 2413136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
    Rook AH; Masur H; Lane HC; Frederick W; Kasahara T; Macher AM; Djeu JY; Manischewitz JF; Jackson L; Fauci AS; Quinnan GV
    J Clin Invest; 1983 Jul; 72(1):398-403. PubMed ID: 6308051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
    Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
    J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.
    Murray HW; Welte K; Jacobs JL; Rubin BY; Mertelsmann R; Roberts RB
    J Clin Invest; 1985 Nov; 76(5):1959-64. PubMed ID: 2997299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms in congenital cytomegalovirus infection: activation of CMV-specific T helper cells (CMV-Th) by exogenous IL-2.
    Gehrz RC; Peterson ES; Liu YN
    Clin Exp Immunol; 1988 Dec; 74(3):333-8. PubMed ID: 2853015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus (CMV): specific lymphokine production in congenital CMV infection.
    Gehrz RC; Leonard TE
    Clin Exp Immunol; 1985 Dec; 62(3):507-14. PubMed ID: 3002688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
    Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
    Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody levels for cytomegalovirus, herpes simplex virus, and rubella in patients with acquired immune deficiency syndrome.
    Halbert SP; Kiefer DJ; Friedman-Kien AE; Poiesz B
    J Clin Microbiol; 1986 Feb; 23(2):318-21. PubMed ID: 3009534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished interleukin 2 production and receptor generation characterize the acquired immunodeficiency syndrome.
    Ebert EC; Stoll DB; Cassens BJ; Lipshutz WH; Hauptman SP
    Clin Immunol Immunopathol; 1985 Dec; 37(3):283-97. PubMed ID: 2932269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus infections in the acquired immune deficiency syndrome.
    Quinnan GV; Masur H; Rook AH; Armstrong G; Frederick WR; Epstein J; Manischewitz JF; Macher AM; Jackson L; Ames J
    JAMA; 1984 Jul; 252(1):72-7. PubMed ID: 6328055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
    Donnenberg AD; Chaikof E; Aurelian L
    Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.